Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica

Milan, Lombardy 20141

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) — Completed
• A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) — Completed